Eizen Joshua M
SEC insider (Form 3/4/5 filer). CIK 0001949621. Officer at AN2 Therapeutics, Inc. (ANTX). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in MENLO PARK, CA.
Companies Eizen Joshua M has filed insider reports for
- AN2 Therapeutics, Inc. (ANTX): Officer, See Remarks
Eizen Joshua M
CIK: 0001949621
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AN2 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 8, 2026ANTX
AN2 Therapeutics, Inc.
SaleDirect5.9K shares at avg. $4.17$25K - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
50.2K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
92K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
50.2K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
92K shares- - Feb 20, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirect50K shares- - Jan 6, 2026ANTX
AN2 Therapeutics, Inc.
SaleDirect6.9K shares at avg. $1.01$7K - Jan 5, 2026ANTX
AN2 Therapeutics, Inc.
SaleDirect17.9K shares at avg. $1.00$18K - Nov 4, 2025ANTX
AN2 Therapeutics, Inc.
SaleDirect2.8K shares at avg. $1.14$3K - Feb 26, 2025ANTX
AN2 Therapeutics, Inc.
AwardDirect58.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 5,945 | $4.17 | $24,803 | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Disposition Stock Option (right to buy) | 50,150 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 92,000 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 50,150 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Disposition Stock Option (right to buy) | 92,000 | - | - | Direct |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc. | Award | 50,000 | - | $0 | Direct |
| Jan 6, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 6,931 | $1.01 | $7,014 | Direct |
| Jan 5, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 17,923 | $1.00 | $17,948 | Direct |
| Nov 4, 2025 | ANTX AN2 Therapeutics, Inc. | Sale | 2,819 | $1.14 | $3,214 | Direct |
| Feb 26, 2025 | ANTX AN2 Therapeutics, Inc. | Award | 58,500 | - | - | Direct |
1-10 of 12 transactions